THE HEMATO-ONCOLOGY INSTITUTE OF ISRAELThe Sheba Institute of Hemato-Oncology was founded in 1953 by Prof. Braha Ramot, the laureate of the Israel Award in the sphere of medicine. Today this institute is the largest facility of its kind in all of Israel. The Institute offers a comprehensive approach to the diagnosis and treatment of blood diseases, especially hematologic cancer. Doctors work in continuous cooperation with laboratory staff to guarantee immediate clinical assessment of test results.
What are the diseases treated at the Institute of Hemato-Oncology?
- Acute Lymphoblastic Leukemia (ALL), Adult and Child
- Chronic Lymphocytic Leukemia(CLL)
- Acute Myeloid Leukemia (AML)
- Chronic Myeloid Leukemia (CML)
- B-Cell Acute Lymphoblastic Leukemia(B ALL)
- Hodgkin's Lymphoma
- Non-Hodgkin Lymphoma (NHL), Adult and Child
- Anaplastic large cell lymphoma.
- Peripheral T cell lymphoma not otherwise specified.
- Angioimmunoblastic lymphoma.
- Hepatosplenic T-cell lymphoma.
- Extranodal NK/T-cell lymphoma.
- Multiple myeloma.
Types of treatments offered:
- Cancer Immunotherapy
- Radiation Therapy
- Bone Marrow Transplantation
- Targeted Therapy
- Chemotherapy Treatment
- Other advanced treatments
CONTACT US TO GET A TREATMENT OFFER FOR YOUR INDIVIDUAL CONDITION
About hematologic cancers
The head of the Institute of Hemato-Oncology is PROF. ARNON NAGLER.Prof. Nagler specializes in internal diseases, hematology, bone marrow transplantation and umbilical cord blood transplant. He obtained advanced training in hemato-oncology and bone marrow transplantation at Stanford University (Stanford, USA). He has also served as the head of the umbilical cord blood bank at Sheba Medical Center (Tel HaShomer) since 2001. Prof. Nagler is one of the world's leaders in the field of umbilical cord blood storage and processing as well as stem cells preparation.
Prof. Nagler is one of the founders of the European net of umbilical cord blood banks and organ transplantation products. The umbilical cord blood bank at Sheba Medical Center recently obtained international accreditation. Arnon Nagler won many awards in the field of hematology and organ transplant and holds more than 40 patents. He has served the head researcher for 15 clinical trials and is an internationally recognized lecturer. Prof. Nagler received more than 40 grants from the government, science foundations and pharmaceutical companies and has published hundreds of books and academic papers.
Prof. Nagler holds the title of Professor of Medicine at Tel Aviv University. Among his other duties, Prof. Nagler held the posts of Technical Director and Counselor at Hamida Biopharmaceutical Company, where he developed stem cell apheresis technology.
Read Prof. Nagler's full resume >>
OTHER SPECIALISTS IN THE DEPARTMENT:
Abraham Avigdor, MD
Director of the Institute of Hematology
Dr. Hila Magen,MD
Head of Sheba’s Multiple Myeloma and Amyloidosis Unit
Prof. Amos Toren, MD, PhD, MHA
Director of the Pediatric Hemato-Oncology and BMT Department
Attending Physician at the Pediatric Hematology and Oncology Department
Ivetta Danylesko, MD
Attending Physician at the BMT Unit of the Hemato-Oncology Division
The Israel Institute of Hemato-Oncology provides each patient with an individualized treatment, complimented by a warm relationship with staff, and 24/7 patient health monitoring.
Equipment available at the Hemato-Oncologic wards
Individual hospital wards have satellite television, stereo systems and other equipment to make the hospital stay more pleasant both for the patient and any accompanying person. The hospital specifically provides roomy and well-equipped space for any accompanying person.